Gynecologic Oncology | Interview with Kathleen Moore, MD - a podcast by Dr Neil Love

Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer — Interview with Dr Moore on the following topics:

• Genomic testing for patients with newly diagnosed ovarian cancer (OC) (00:00)
• Management of OC with germline BRCA mutation after surgical debulking; role of bevacizumab and PARP inhibitors (3:40)
• Therapeutic approach for patients with homologous recombination-proficient OC (8:20)

CME information and select publications

Further episodes of Research To Practice | Oncology Videos

Further podcasts by Dr Neil Love

Website of Dr Neil Love